Herman Waldmann
From Wikipedia, the free encyclopedia
Herman Waldmann, FRS, is a British immunologist (born 27 February 1945). He worked in the Department of Pathology, University of Cambridge, from 1973, becoming head of the Immunology Division in 1989. He was made a Fellow of the Royal Society in 1990. In 1994, he took up the position of head of the Sir William Dunn School of Pathology at the University of Oxford.
Waldmann is best known for his work on therapeutic monoclonal antibodies, particularly Campath-1, now licensed as alemtuzumab for the treatment of chronic lymphocytic leukemia.
[edit] External links
- Biography at ISI Highly Cited Researchers
- Sir William Dunn School of Pathology Therapeutic Immunology Group -- photo, links to CV & publications list
- From laboratory to clinic: the story of CAMPATH-1 (Geoff Hale and Herman Waldmann)
 |
This article about a biologist is a stub. You can help Wikipedia by expanding it. |
